| pubmed-article:11844668 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11844668 | lifeskim:mentions | umls-concept:C0001128 | lld:lifeskim |
| pubmed-article:11844668 | lifeskim:mentions | umls-concept:C0002482 | lld:lifeskim |
| pubmed-article:11844668 | lifeskim:mentions | umls-concept:C0038477 | lld:lifeskim |
| pubmed-article:11844668 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
| pubmed-article:11844668 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
| pubmed-article:11844668 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
| pubmed-article:11844668 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:11844668 | pubmed:dateCreated | 2002-3-7 | lld:pubmed |
| pubmed-article:11844668 | pubmed:abstractText | We have described 5-(4-propoxycinnamoylamino)-2-(4-tolylacetylamino)benzophenone 6e as a novel lead for anti-malarial agents. Anti-malarial activity of these 5-(4-propoxycinnamoylamino)benzophenones proved to be quite sensitive against variations of the acyl substituent at the 2-amino group. Best activity was obtained with phenylacetic acid moieties carrying small substituents in the para-position. From the para-substituents evaluated, the trifluoromethyl group yielded the most active compound (6j) in this series (IC50=120 nM). Deviations from the phenylacetic acid substructure, shifting the substituent into the ortho-position or bulkier para-substituents resulted in a significant reduction in anti-malarial activity. | lld:pubmed |
| pubmed-article:11844668 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11844668 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11844668 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11844668 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11844668 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11844668 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11844668 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11844668 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11844668 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11844668 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11844668 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:11844668 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:11844668 | pubmed:author | pubmed-author:SchlitzerMart... | lld:pubmed |
| pubmed-article:11844668 | pubmed:author | pubmed-author:WiesnerJochen... | lld:pubmed |
| pubmed-article:11844668 | pubmed:author | pubmed-author:JomaaHassanH | lld:pubmed |
| pubmed-article:11844668 | pubmed:author | pubmed-author:KettlerKatjaK | lld:pubmed |
| pubmed-article:11844668 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11844668 | pubmed:day | 25 | lld:pubmed |
| pubmed-article:11844668 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:11844668 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11844668 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11844668 | pubmed:pagination | 543-5 | lld:pubmed |
| pubmed-article:11844668 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:11844668 | pubmed:meshHeading | pubmed-meshheading:11844668... | lld:pubmed |
| pubmed-article:11844668 | pubmed:meshHeading | pubmed-meshheading:11844668... | lld:pubmed |
| pubmed-article:11844668 | pubmed:meshHeading | pubmed-meshheading:11844668... | lld:pubmed |
| pubmed-article:11844668 | pubmed:meshHeading | pubmed-meshheading:11844668... | lld:pubmed |
| pubmed-article:11844668 | pubmed:meshHeading | pubmed-meshheading:11844668... | lld:pubmed |
| pubmed-article:11844668 | pubmed:meshHeading | pubmed-meshheading:11844668... | lld:pubmed |
| pubmed-article:11844668 | pubmed:meshHeading | pubmed-meshheading:11844668... | lld:pubmed |
| pubmed-article:11844668 | pubmed:meshHeading | pubmed-meshheading:11844668... | lld:pubmed |
| pubmed-article:11844668 | pubmed:meshHeading | pubmed-meshheading:11844668... | lld:pubmed |
| pubmed-article:11844668 | pubmed:meshHeading | pubmed-meshheading:11844668... | lld:pubmed |
| pubmed-article:11844668 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11844668 | pubmed:articleTitle | Structure-activity relationships of novel anti-malarial agents. Part 3: N-(4-acylamino-3-benzoylphenyl)-4-propoxycinnamic acid amides. | lld:pubmed |
| pubmed-article:11844668 | pubmed:affiliation | Biochemisches Institut der Universitatsklinik Giessen, Friedrichstrasse 24, D-35249, Giessen, Germany. | lld:pubmed |
| pubmed-article:11844668 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:11844668 | lld:chembl |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11844668 | lld:pubmed |
